Use of immunological markers and continuous-time Markov models to estimate progression of HIV infection in homosexual men

AIDS

Volumn 10, Issue 6, 1996, Pages 649-656

  Hendriks, Jan C M ^a,b   Satten, Glen A ^c   Longini, Ira M ^c   Van Druten, Hans A M ^b   Schellekens, Peter Th A ^d   Coutinho, Roel A ^a   Van Griensven, Godfried J P ^a  

^a MUNICIPAL HEALTH SERVICE   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^c EMORY UNIVERSITY   (United States)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Anti CD3 reactivity; CD4 counts; HIV disease progression; Homosexual men; Immunological marker; Incubation period distribution; Markov model

Indexed keywords

MONOCLONAL ANTIBODY CD3;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; COHORT ANALYSIS; DISEASE COURSE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PRIORITY JOURNAL; SEROCONVERSION; STATISTICAL MODEL;

EID: 0029899169     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199606000-00011     Document Type: Article

References (25)

1. McLean AR, Nowak MA: The interaction between HIV and other pathogens. J Theor Biol 1991, 155:69-102.
2. Bass HZ, Hardy WD, Mitsuyasu RT, Wang Y-X, Cumberland W, Fahey JL: Eleven lymphoid phenotypic markers in HIV infection: selective changes induced by zidovudine treatment. J Acquir Immune Defic Syndr 1992, 5:890-897.
3. Cooper DA, Gatell JM, Kroon S, et al.: Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimetre. N Engl J Med 1993, 329:297-303.
4. Muǹoz A, Wang M-C, Bass S, et al.: Acquired immunodeficiency syndrome (AIDS)-free time after human immunodeficiency virus type 1 (HIV-1) seroconversion in homosexual men. Am J Epidemiol 1989, 130:530-539.
5. Hoover DR, Muǹoz A, Carey V, et al.: Estimating the 1978-1990 and future spread of human immunodeficiency virus type-1 in subgroups of homosexual men. Am J Epidemiol 1991, 134:1190-1205.
6. Longini IM, Clark WS, Gardner LI, Brundage JF: The dynamics of CD4+ T-lymphocyte decline in HIV-infected individuals: a Markov modelling approach. J Acquir Immune Defic Syndr 1991, 4:1141-1147.
7. Longini IM, Clark WS, Karon JM: Effect of routine use of therapy in slowing the clinical course of human immunodeficiency virus (HIV) infection in a population-based-cohort. Am J Epidemiol 1993, 137:1229-1240.
8. Satten GA, Longini IM Jr: Markov chains with measurement error: estimating the 'true' course of a marker of HIV disease progression. Appl Stat 1996 (in press).
9. Hendriks JCM, Medley GF, van Griensven GJP, Coutinho RA, Heisterkamp SH, van Druten HAM: The treatment-free incubation period of AIDS in a cohort of homosexual men. AIDS 1993, 7:231-239.
10. Simmonds P, Beatson D, Cuthbert RJ, et al.: Determinants of HIV disease progression. Lancet 1991, 338:1159-1163.
11. Cuthbert RJ, Ludlam CA, Tucker J, et al.: Five-year study of HIV infection in the Edinburgh haemophiliac cohort. BMJ 1990, 301:956-961.
12. Melmed RN, Taylor JMG, Detels R, et al.: Serum neopterin changes in HIV-infected subjects. J Acquir Immune Defic Syndr 1989, 2:70-76.
13. Schellekens PThA, Roos MThL, De Wolf F, Lange JMA, Miedema F: Low T-cell responsiveness to activation via CD3/TCR is a prognostic marker for acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus-1 (HIV-1)-infected men. J Clin Immunol 1990, 10:121-127.
14. Roos MTL, Miedema F, Koot M, et al.: T-cell function in vitro as an independent progression marker for AIDS in human immunodeficiency virus HIV-infected asymptomatic individuals. J Infect Dis 1995, 171:531-536.
15. van Griensven GJP, Tielman RAP, Goudsmit J, et al.: Risk factors and prevalence of HIV antibodies in homosexual men in the Netherlands. Am J Epidemiol 1987, 125:1048-1057.
16. De Wolf F, Lange JMA, Houweling JTM, et al.: Numbers of CD4+ cells and the levels of core antigens and of antibodies to the human immunodeficiency virus as predictors of AIDS among homosexual men. J infect Dis 1988, 158:615-622.
17. Centers for Disease Control: Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987, 36:35-155.
18. Miedema F, Petit AJC, Terpstra FG, et al: Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. J Clin Invest 1988, 82:1908-1914.
19. Bloemena E, Roos MTL, Van Heijst JLAM, Vossen JMJJ, Schellekens PTA: Whole-blood lymphocyte cultures. J Immunol Methods 1989, 122:161-167.
20. Chiang CL: An introduction to stochastic processes and their applications. New York: Krieger; 1980.
21. Härdle W: Applied nonparametric regression. Cambridge: Cambridge University Press; 1990.
22. Hughes MD, Stein DS, Gundacker HM, Valentine FT, Phair JP, Volberding PA: Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: implications for patient monitoring. J Infect Dis 1994, 169:28-36.
23. Hoover DR, Graham NMH, Chen B, et al.: Effect of CD4+ cell count measurement variability on staging HIV-1 infection. J Acquir Immune Defic Syndr 1992, 5:794-802.
24. Longini JM, Clark WS, Byers RH, et al.: Statistical analysis of the stages of HIV infection using a Markov model. Stat Med 1989, 8:831-843.
25. Efron B: The Jackknife, the Bootstrap and Other Resampling Plans. Philadelphia: SIAM; 1982.